Connaughton Bernadette 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Connaughton Bernadette
Director
Transactions
- Sale
Common Stock
2026-01-05$70.25/sh−2,000$140,500→ 40,123 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1.